LBA20 First-line Carboplatin-Cyclophosphamide (CC) Versus Paclitaxel (P) with or Without Atezolizumab (atezo) for Metastatic Triple Negative Breast Cancer (mtnbc): Results from a Multicenter, Randomized Phase IIb Trial: the Triple-B Study (BOOG 2013-01)
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要